BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37843393)

  • 1. Vertebral Body Reshaping after Fractures: An Important Index of Recovery in Glucocorticoid-Treated Children.
    Ma J; Siminoski K; Jaremko JL; Koujok K; Matzinger MA; Shenouda N; Wilson N; Cheng M; Alos N; Atkinson S; Cummings EA; Ho J; Rodd C; Sbrocchi AM; Stein R; Barr R; Cairney E; Dix DB; Fernandez CV; Grant R; Halton J; Israels S; Laverdière C; Lewis VA; Cabral DA; Huber A; Houghton K; Jurencak R; Lang B; Larché M; LeBlanc CMA; Miettunen P; Roth J; Scuccimarri R; Bell L; Blydt-Hansen T; Filler G; Feber J; Phan V; Smit K; Rauch F; Ward LM
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1225-e1237. PubMed ID: 37843393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders.
    Ward LM; Ma J; Robinson ME; Scharke M; Ho J; Houghton K; Huber A; Scuccimarri R; Barsalou J; Roth J; Shenouda N; Matzinger MA; Lentle B; Jaremko JL; Koujok K; Watanabe Duffy K; Stein R; Sbrocchi AM; Rodd C; Miettunen PM; LeBlanc CMA; Larche M; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Sykes E; Konji VN; Rauch F; Siminoski K; Lang B
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5195-e5207. PubMed ID: 34232311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy.
    Phung K; McAdam L; Ma J; McMillan HJ; Jackowski S; Scharke M; Matzinger MA; Shenouda N; Koujok K; Jaremko JL; Smit K; Walker S; Hartigan C; Khan N; Konji VN; MacLeay L; Page M; Sykes E; Robinson ME; Alos N; Cummings EA; Ho J; Sbrocchi AM; Stein R; Saleh D; Craven BC; Dang UJ; Siminoski K; Rauch F; Ward LM
    Osteoporos Int; 2023 Jan; 34(1):147-160. PubMed ID: 36342539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time to and determinants of first fractures in boys with Duchenne muscular dystrophy.
    Ma J; McMillan HJ; Karagüzel G; Goodin C; Wasson J; Matzinger MA; DesClouds P; Cram D; Page M; Konji VN; Lentle B; Ward LM
    Osteoporos Int; 2017 Feb; 28(2):597-608. PubMed ID: 27774565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study.
    Ward LM; Ma J; Lang B; Ho J; Alos N; Matzinger MA; Shenouda N; Lentle B; Jaremko JL; Wilson B; Stephure D; Stein R; Sbrocchi AM; Rodd C; Lewis V; Israels S; Grant RM; Fernandez CV; Dix DB; Cummings EA; Couch R; Cairney E; Barr R; Abish S; Atkinson SA; Hay J; Rauch F; Moher D; Siminoski K; Halton J;
    J Bone Miner Res; 2018 Aug; 33(8):1435-1443. PubMed ID: 29786884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Phan V; Blydt-Hansen T; Feber J; Alos N; Arora S; Atkinson S; Bell L; Clarson C; Couch R; Cummings EA; Filler G; Grant RM; Grimmer J; Hebert D; Lentle B; Ma J; Matzinger M; Midgley J; Pinsk M; Rodd C; Shenouda N; Stein R; Stephure D; Taback S; Williams K; Rauch F; Siminoski K; Ward LM;
    Osteoporos Int; 2014 Feb; 25(2):627-37. PubMed ID: 23948876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy.
    Phung K; McAdam L; Ma J; McMillan HJ; Jackowski S; Scharke M; Matzinger MA; Shenouda N; Koujok K; Jaremko JL; Wilson N; Walker S; Hartigan C; Khan N; Page M; Robinson ME; Saleh DS; Smit K; Rauch F; Siminoski K; Ward LM
    J Clin Endocrinol Metab; 2024 Jan; 109(2):536-548. PubMed ID: 37610420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.
    LeBlanc CM; Ma J; Taljaard M; Roth J; Scuccimarri R; Miettunen P; Lang B; Huber AM; Houghton K; Jaremko JL; Ho J; Shenouda N; Matzinger MA; Lentle B; Stein R; Sbrocchi AM; Oen K; Rodd C; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Rauch F; Siminoski K; Ward LM;
    J Bone Miner Res; 2015 Sep; 30(9):1667-75. PubMed ID: 25801315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.
    Feber J; Gaboury I; Ni A; Alos N; Arora S; Bell L; Blydt-Hansen T; Clarson C; Filler G; Hay J; Hebert D; Lentle B; Matzinger M; Midgley J; Moher D; Pinsk M; Rauch F; Rodd C; Shenouda N; Siminoski K; Ward LM;
    Osteoporos Int; 2012 Feb; 23(2):751-60. PubMed ID: 21494860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid.
    Lee KA; Kim J; Kim HJ; Kim HS
    Int J Rheum Dis; 2021 Aug; 24(8):1053-1060. PubMed ID: 34184827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.
    Ma J; Siminoski K; Alos N; Halton J; Ho J; Cummings EA; Shenouda N; Matzinger MA; Lentle B; Jaremko JL; Wilson B; Stephure D; Stein R; Sbrocchi AM; Rodd C; Lewis VA; Laverdière C; Israels S; Grant RM; Fernandez CV; Dix DB; Couch R; Cairney E; Barr R; Atkinson S; Abish S; Moher D; Rauch F; Ward LM;
    J Clin Endocrinol Metab; 2019 Feb; 104(2):213-222. PubMed ID: 30247635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study.
    Rodd C; Lang B; Ramsay T; Alos N; Huber AM; Cabral DA; Scuccimarri R; Miettunen PM; Roth J; Atkinson SA; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Larché M; LeBlanc C; Oen K; Saint-Cyr C; Stein R; Stephure D; Taback S; Lentle B; Matzinger M; Shenouda N; Moher D; Rauch F; Siminoski K; Ward LM;
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):122-31. PubMed ID: 22213727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical distribution of vertebral fractures: comparison of pediatric and adult spines.
    Siminoski K; Lee KC; Jen H; Warshawski R; Matzinger MA; Shenouda N; Charron M; Coblentz C; Dubois J; Kloiber R; Nadel H; O'Brien K; Reed M; Sparrow K; Webber C; Lentle B; Ward LM;
    Osteoporos Int; 2012 Jul; 23(7):1999-2008. PubMed ID: 22109742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.
    Ward LM
    Front Endocrinol (Lausanne); 2020; 11():576. PubMed ID: 33391179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grade 1 Vertebral Fractures Identified by Densitometric Lateral Spine Imaging Predict Incident Major Osteoporotic Fracture Independently of Clinical Risk Factors and Bone Mineral Density in Older Women.
    Johansson L; Sundh D; Magnusson P; Rukmangatharajan K; Mellström D; Nilsson AG; Lorentzon M
    J Bone Miner Res; 2020 Oct; 35(10):1942-1951. PubMed ID: 32539162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.
    Huber AM; Gaboury I; Cabral DA; Lang B; Ni A; Stephure D; Taback S; Dent P; Ellsworth J; LeBlanc C; Saint-Cyr C; Scuccimarri R; Hay J; Lentle B; Matzinger M; Shenouda N; Moher D; Rauch F; Siminoski K; Ward LM;
    Arthritis Care Res (Hoboken); 2010 Apr; 62(4):516-26. PubMed ID: 20391507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses.
    Florez H; Hernández-Rodríguez J; Carrasco JL; Prieto-González S; Muxi A; Filella X; Ruiz-Gaspà S; Gómez-Puerta JA; Cid M; Espinosa G; Monegal A; Guañabens N; Peris P
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.
    Rudman HA; Birrell F; Pearce MS; Tuck SP; Francis RM; Treadgold L; Hind K
    Osteoporos Int; 2019 Apr; 30(4):829-836. PubMed ID: 30623213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Radiology of Vertebral Fractures in Childhood Osteoporosis Related to Glucocorticoid Administration.
    Lentle B; Ma J; Jaremko JL; Siminoski K; Matzinger MA; Shenouda N; Konji VN; Ward LM
    J Clin Densitom; 2016; 19(1):81-8. PubMed ID: 26653615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.